CSat Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-29
Closed -$7K 803
2020
Q3
$7K Buy
29
+4
+16% +$966 ﹤0.01% 1072
2020
Q2
$9K Sell
25
-31
-55% -$11.2K ﹤0.01% 1058
2020
Q1
$15K Buy
56
+9
+19% +$2.41K ﹤0.01% 793
2019
Q4
$15K Sell
47
-376
-89% -$120K ﹤0.01% 872
2019
Q3
$115K Buy
423
+285
+207% +$77.5K 0.04% 287
2019
Q2
$74K Buy
138
+49
+55% +$26.3K 0.03% 354
2019
Q1
$45K Buy
89
+17
+24% +$8.6K 0.02% 172
2018
Q4
$35K Buy
72
+53
+279% +$25.8K 0.02% 179
2018
Q3
$17K Sell
19
-5
-21% -$4.47K 0.01% 256
2018
Q2
$18K Buy
+24
New +$18K 0.01% 219